Repeated surgical resections for management of high-grade glioma and its impact on quality of life

被引:2
|
作者
Koay, Jun Min [1 ,2 ]
Michaelides, Loizos [3 ]
Moniz-Garcia, Diogo P. [3 ]
Quinones-Hinojosa, Alfredo [3 ]
Chaichana, Kaisorn [3 ]
Almeida, Joao Paulo [3 ]
Gruenbaum, Benjamin F. [4 ]
Sherman, Wendy J. [3 ,5 ]
Sabsevitz, David S. [2 ,3 ]
机构
[1] Mayo Clin, Dept Psychiat & Psychol, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Psychiat & Psychol, Jacksonville, FL 32224 USA
[3] Mayo Clin, Dept Neurol Surg, Jacksonville, FL USA
[4] Mayo Clin, Dept Anesthesiol & Perioperat Med, Jacksonville, FL USA
[5] Mayo Clin, Dept Neurol, Jacksonville, FL USA
关键词
Quality of life; Glioma; Repeated resection; Onco-functional balance; Neuropsychology; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL ASSESSMENT; CANCER-THERAPY; FACT-G; SURVIVAL; CLASSIFICATION; MULTICENTER; RECURRENCE; DEFICITS; TUMORS;
D O I
10.1007/s11060-024-04600-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose High-grade gliomas (HGG) are aggressive cancers, and their recurrence is inevitable, despite advances in treatment options. While repeated tumor resection has been shown to increase survival rate, its impact on quality of life is not clearly defined. To address this gap, we compared quality of life (QoL) changes in HGG patients who underwent first-time (FTR) versus repeat surgical resections (RSR) for management of recurrence. Methods Forty-four adults with HGG who underwent tumor resection were included in this study and classified into either the FTR group (n = 23) or the RSR group (n = 21). All patients completed comprehensive neuropsychological evaluations that included the Functional Assessment of Cancer Therapy-General (FACT-G) and Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) scales, pre-operatively and at two weeks post-operatively. Results There was no difference between the FTR and RSR groups in any of the QoL indices (all p > .05), except for improved emotional well-being and worsened social well-being, suggesting minimal detrimental effects of repeat surgeries on QoL in comparison to first time surgery. Conclusions These results suggest that repeated resection is a viable strategy in certain cases for management of HGG recurrence, with similar impact on QoL as observed in patients undergoing first time surgery. These encouraging outcomes provide useful insight to guide treatment strategies and patient and clinician decision making to optimize surgical and functional outcomes.
引用
收藏
页码:267 / 273
页数:7
相关论文
共 50 条
  • [31] The effects of hyperglycemia on outcomes in surgical high-grade glioma patients
    Decker, Matthew
    Sacks, Patricia
    Abbatematteo, Joseph
    De Leo, Edward
    Brennan, Meghan
    Rahman, Maryam
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2019, 179 : 9 - 13
  • [32] Interaction of quality of life, mood and depression of patients and their informal caregivers after surgical treatment of high-grade glioma: a prospective study
    Maxi Sacher
    Jürgen Meixensberger
    Wolfgang Krupp
    Journal of Neuro-Oncology, 2018, 140 : 367 - 375
  • [33] Interaction of quality of life, mood and depression of patients and their informal caregivers after surgical treatment of high-grade glioma: a prospective study
    Sacher, Maxi
    Meixensberger, Juergen
    Krupp, Wolfgang
    JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (02) : 367 - 375
  • [34] Recurrent High-Grade Glioma
    Eudocia C. Quant
    Jan Drappatz
    Patrick Y. Wen
    Andrew D. Norden
    Current Treatment Options in Neurology, 2010, 12 : 321 - 333
  • [35] Pseudoprogression in high-grade glioma
    Knudsen-Baas, K. M.
    Moen, G.
    Fluge, O.
    Storstein, A.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 127 : 31 - 37
  • [36] Vincristine in High-grade Glioma
    Aydin, Burca
    Patil, Monali
    Bekele, Nebiyou
    Wolff, Johannes E. A.
    ANTICANCER RESEARCH, 2010, 30 (06) : 2303 - 2310
  • [37] Chemotherapy for high-grade glioma
    Burdett, S
    Stewart, L
    NEUROEPIDEMIOLOGY, 2003, 22 (06) : 366 - 366
  • [38] Recurrent High-Grade Glioma
    Quant, Eudocia C.
    Drappatz, Jan
    Wen, Patrick Y.
    Norden, Andrew D.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2010, 12 (04) : 321 - 333
  • [39] Radioimmunotherapy for high-grade glioma
    De Bonis, Pasquale
    Lofrese, Giorgio
    Anile, Carmelo
    Pompucci, Angelo
    Vigo, Vera
    Mangiola, Annunziato
    IMMUNOTHERAPY, 2013, 5 (06) : 647 - 659
  • [40] Immunotherapy for high-grade glioma
    Dixit, Sanjay
    FUTURE ONCOLOGY, 2014, 10 (06) : 911 - 915